Relay Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Relay Therapeutics, Inc. (RLAY) reported Earnings Per Share, Basic and Diluted of -$0.71 per share for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-08-04
- Relay Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-06-30 was -$0.71.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.57.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.66, a 267.83% decline year-over-year.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.66.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2021 was -$3.82.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.40.
- Relay Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$21.82.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$0.71 10-Q · filed 2022-08-04 | -$1.28 10-Q · filed 2022-08-04 | ||
| 2022-03-31 | -$0.57 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.31 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$3.82 10-K · filed 2022-02-24 | |
| 2021-09-30 | -$0.66 10-Q · filed 2021-11-10 | -$3.20 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | -$2.10 10-Q · filed 2022-08-04 | -$2.58 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$0.47 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.39 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.21 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$5.40 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$3.00 10-Q · filed 2021-11-10 | -$9.92 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$6.06 10-Q · filed 2021-08-12 | -$12.06 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$5.99 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$6.24 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$11.80 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$21.82 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$5.53 10-Q · filed 2020-11-12 | -$15.46 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$5.28 10-Q · filed 2020-08-27 | -$9.90 10-Q · filed 2020-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |